| John Steuart Richards, | |
|
3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213-3403 | |
| (412) 647-6700 | |
| Not Available |
| Full Name | John Steuart Richards |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 3601 5th Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396846150 | NPI | - | NPPES |
| MD455725 | Other | PA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD455725 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Pittsburgh Physicians | 8729990239 | 3721 |
News Archive
A study published in the open access journal, BMC Public Health, shows that the content of advertisements in black or Latino magazines may contribute to the lower health status observed in African-American and Hispanic populations in the USA.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine researchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.
› Verified 6 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A study published in the open access journal, BMC Public Health, shows that the content of advertisements in black or Latino magazines may contribute to the lower health status observed in African-American and Hispanic populations in the USA.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine researchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Steuart Richards, 2 Hot Metal St, Quantum One Suite 001, Pittsburgh, PA 15203-2348 Ph: () - | John Steuart Richards, 3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213-3403 Ph: (412) 647-6700 |
News Archive
A study published in the open access journal, BMC Public Health, shows that the content of advertisements in black or Latino magazines may contribute to the lower health status observed in African-American and Hispanic populations in the USA.
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin and halt a model of relapsing remitting multiple sclerosis (MS) in mice, according to new Northwestern Medicine research.
Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.
Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine researchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD.
› Verified 6 days ago
Krishna Kancharla, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5200 Centre Ave, Suite 710, Pittsburgh, PA 15232 Phone: 412-623-6889 | |
Christine Peoples, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213 Phone: 412-647-6700 | |
Rima Abdel Massih, Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 5th Ave, Suite 3a, Pittsburgh, PA 15213 Phone: 412-648-6273 | |
Dr. Matthew Michael Lander, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-6500 | |
Allie Dakroub, MD MS Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop Street, Suite 9 South, Pittsburgh, PA 15213 Phone: 412-692-4888 | |
Katrina Han, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave Bldg Suite3a, Pittsburgh, PA 15213 Phone: 412-586-9700 | |
Omar Khaled Osman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste B300, Pittsburgh, PA 15212 Phone: 412-359-3751 |